Spyre Therapeutics (SYRE) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Spyre Therapeutics (SYRE) over the last 11 years, with Q1 2025 value amounting to $10000.0.
- Spyre Therapeutics' Non-Current Assets fell 9696.05% to $10000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $20000.0, marking a year-over-year decrease of 9800.2%. This contributed to the annual value of $10000.0 for FY2024, which is 9697.89% down from last year.
- Latest data reveals that Spyre Therapeutics reported Non-Current Assets of $10000.0 as of Q1 2025, which was down 9696.05% from $10000.0 recorded in Q4 2024.
- Spyre Therapeutics' 5-year Non-Current Assets high stood at $12.6 million for Q2 2021, and its period low was $10000.0 during Q3 2024.
- In the last 5 years, Spyre Therapeutics' Non-Current Assets had a median value of $8.1 million in 2023 and averaged $5.9 million.
- In the last 5 years, Spyre Therapeutics' Non-Current Assets skyrocketed by 1603.27% in 2021 and then plummeted by 9924.01% in 2024.
- Spyre Therapeutics' Non-Current Assets (Quarter) stood at $11.0 million in 2021, then dropped by 19.47% to $8.9 million in 2022, then tumbled by 96.28% to $331000.0 in 2023, then plummeted by 96.98% to $10000.0 in 2024, then changed by 0.0% to $10000.0 in 2025.
- Its Non-Current Assets stands at $10000.0 for Q1 2025, versus $10000.0 for Q4 2024 and $10000.0 for Q3 2024.